Hyaluronic acid can bind specifically to the CD44 receptor of breast cancer cells, while Prussian blue acts as a PTA for PTT, and CS-6 is an anti-tumor drug that inhibits VEGF-induced angiogenesis in vitro, on cancer cells, and in vivo on mouse tumor xenografts. This evidence concerns the gene VEGFA and neoplasm.